Literature DB >> 22434720

A functional network of the tumor suppressors APC, hDlg, and PTEN, that relies on recognition of specific PDZ-domains.

Natalia S Sotelo1, Miguel Valiente, Anabel Gil, Rafael Pulido.   

Abstract

APC and PTEN are tumor suppressor proteins that bind through their C-termini to the PDZ domain containing-hDlg scaffolding protein. We have found that co-expression of PTEN and hDlg enhanced the negative regulation of the PI3K/Akt pathway by PTEN, indicating the physiologic importance of these interactions. APC and PTEN share other PDZ domain containing-interacting partners, including the MAGI scaffolding proteins and the MAST family of protein kinases. Mutational analysis revealed that the C-terminal PDZ-binding motifs from APC and PTEN were differentially recognized by distinct PDZ domains. APC bound to the three PDZ domains from hDlg, whereas PTEN mainly bound to PDZ-2/hDlg. This indicates the existence of overlapping, but distinct PDZ-domain recognition patterns by APC and PTEN. Furthermore, a ternary complex formed by APC, PTEN, and hDlg was detected, suggesting that hDlg may serve as a platform to bring in proximity APC and PTEN tumor suppressor activities. In line with this, tumor-related mutations targeting the PDZ-2/hDlg domain diminished its interaction with APC and PTEN. Our results expand the PDZ-domain counterparts for the tumor suppressor APC, show that APC and PTEN share PDZ-domain partners but have individual molecular determinants for specific recognition of PDZ domains, and suggest the participation of the tumor suppressors APC, PTEN, and hDlg in PDZ-domain interaction networks which may be relevant in oncogenesis.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22434720     DOI: 10.1002/jcb.24141

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  16 in total

Review 1.  PTEN function: the long and the short of it.

Authors:  Benjamin D Hopkins; Cindy Hodakoski; Douglas Barrows; Sarah M Mense; Ramon E Parsons
Journal:  Trends Biochem Sci       Date:  2014-03-18       Impact factor: 13.807

2.  Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function.

Authors:  Antonella Papa; Lixin Wan; Massimo Bonora; Leonardo Salmena; Min Sup Song; Robin M Hobbs; Andrea Lunardi; Kaitlyn Webster; Christopher Ng; Ryan H Newton; Nicholas Knoblauch; Jlenia Guarnerio; Keisuke Ito; Laurence A Turka; Andy H Beck; Paolo Pinton; Roderick T Bronson; Wenyi Wei; Pier Paolo Pandolfi
Journal:  Cell       Date:  2014-04-24       Impact factor: 41.582

3.  MotifAnalyzer-PDZ: A computational program to investigate the evolution of PDZ-binding target specificity.

Authors:  Jordan Valgardson; Robin Cosbey; Paul Houser; Milo Rupp; Raiden Van Bronkhorst; Michael Lee; Filip Jagodzinski; Jeanine F Amacher
Journal:  Protein Sci       Date:  2019-11-01       Impact factor: 6.725

4.  Akt Pathway Activation by Human T-cell Leukemia Virus Type 1 Tax Oncoprotein.

Authors:  Mathew A Cherian; Hicham H Baydoun; Jacob Al-Saleem; Nikoloz Shkriabai; Mamuka Kvaratskhelia; Patrick Green; Lee Ratner
Journal:  J Biol Chem       Date:  2015-08-31       Impact factor: 5.157

Review 5.  Posttranslational Regulation and Conformational Plasticity of PTEN.

Authors:  Larissa Kotelevets; Barbara Trifault; Eric Chastre; Mark G H Scott
Journal:  Cold Spring Harb Perspect Med       Date:  2020-07-01       Impact factor: 5.159

6.  Expression of polarity genes in human cancer.

Authors:  Wan-Hsin Lin; Yan W Asmann; Panos Z Anastasiadis
Journal:  Cancer Inform       Date:  2015-03-30

7.  The human adenovirus E4-ORF1 protein subverts discs large 1 to mediate membrane recruitment and dysregulation of phosphatidylinositol 3-kinase.

Authors:  Kathleen Kong; Manish Kumar; Midori Taruishi; Ronald T Javier
Journal:  PLoS Pathog       Date:  2014-05-01       Impact factor: 6.823

Review 8.  Cell polarity signaling in the plasticity of cancer cell invasiveness.

Authors:  Aneta Gandalovičová; Tomáš Vomastek; Daniel Rosel; Jan Brábek
Journal:  Oncotarget       Date:  2016-05-03

Review 9.  Focus on PTEN Regulation.

Authors:  Miriam Bermúdez Brito; Evangelia Goulielmaki; Evangelia A Papakonstanti
Journal:  Front Oncol       Date:  2015-07-27       Impact factor: 6.244

Review 10.  Viral Interactions with PDZ Domain-Containing Proteins-An Oncogenic Trait?

Authors:  Claire D James; Sally Roberts
Journal:  Pathogens       Date:  2016-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.